Kazakhstan floats its national currency, tenge, allowing the
market to determine the tenge rate. Despite uncertainty in the
strength of local currency, Kazakhstan is still pursuing the
attraction of new investments in the domestic market, including the
coming EXPO-2017. This issue of the Market eyesight will focus on
the country's decision to float tenge, as well as new legal
conditions for the investors in certain sectors of
Taxation of Subsoil Users
The Government of Kazakhstan will reduce the rate of the oil and
gas, mining and chemical industries starting from September,
Following certain analytical researches of oil and gas companies
and reduce the tax rate in order to stimulate the operations. This
is the opportunity to reduce the general tax burden on such
companies by 80%, around 46 billion tenge.
The Government is also planning to issue a number of
The New Antitrust Regulation
By 2017 Kazakhstan will move to the OECD standards
This will allow investors to plan their costs, and will tighten
control over the implementation of investment programs.
EXPO 2017 Participants
India along with China have expressed willingness to participate
in the Expo 2017 in Kazakhstan.
The participation might give a new impulse to the strengthening
of Kazakh-Indian strategic partnership, along with opening new
areas of cooperation, in particular in the field of
R. Zhoshybayev (the First Deputy Minister of Foreign Affairs)
met representatives of the Ministries of Foreign Affairs, Trade and
Industry, Tourism in India, India Trade Promotion Organization
(ITPO), the Association of Tour Operators, as well as high-level
representatives of the Confederation of Indian Industry along with
leading Indian companies in the field of renewable energy sources
During the meeting, the Ministry of Commerce and Industry of
India discussed issues of bilateral trade and economic relations,
prospects of cooperation in the field of «green» energy
and interaction of relevant government agencies and companies of
the two countries for participation in the exhibition.
As regards Chinese participation, it intends to present to the
world the concept of energy development. Kazakhstan is currently
considering the issue of simplification of tourism for Chinese
citizens in Kazakhstan, including through the signing two
agreements with leading Chinese tour operators.
Potential PPP projects in healthcare in Almaty and
The hospital for 300 beds in Almaty is planned for
construction as the concession project, with an estimated value of
$90 million US dollars. The Ministry of Health will provide the
exclusive right to build and operate to the concessionaire for the
period of 25 years. Similar concession project is planned for
construction in Kyzylorda. The local skimpy as the initiator of the
project is planning to attract investors for the construction and
operation of the facility. The available financial models are
planned to be employed based on the principles of PPP.
Both projects will aim to attract potential concessionaires,
experienced in construction and operation of similar facilities
within the realities of Kazakhstan environment.
The competition law enforcement in Turkey is based on private and public enforcement pillars. TCA has sole discretion to enforce the Competition Act whereas the litigations initiated by the victims of anti-competitive conduct are seen in private courts.
Daiichi Sankyo İlaç Ticaret Ltd. Şti. ("Daiichi"), a globally active company in the distribution, sale, marketing and importation of pharmaceutical products, and Aksel Ecza Deposu A.Ş. ("Aksel"), a drug wholesaler, entered into a vertical exclusivity agreement ("Agreement").
The Competition Board concluded its investigation with regard to the booking services provided by Booking.com B.V. and by Bookingdotcom Destek Hizmetleri LLC, operating as the Turkish representative of Booking.com.
For the past few years, Turkey has tended to use various trade remedy tools more frequently, thus the number of investigations increases in depth and breadth with the aim of supporting domestic industry...
The CAT in the UK heard on 17 January 2017 an application by Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd to suspend the Competition and Markets Authority's direction to reduce the price of an epilepsy drug.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).